Prognostic Stage IV Breast Cancer AJCC v8 Active Not Recruiting Phase 1 Trials for Fluciclovine (18F) (DB13146)

IndicationStatusPhase
DBCOND0109667 (Prognostic Stage IV Breast Cancer AJCC v8)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04750473Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast CancerDiagnostic